| TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma SE Josefsson, K Beiske, YN Blaker, MS Førsund, H Holte, B Østenstad, ... Cancer immunology research 7 (3), 355-362, 2019 | 99 | 2019 |
| T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling SE Josefsson, K Huse, A Kolstad, K Beiske, D Pende, CB Steen, ... Clinical Cancer Research 24 (4), 870-881, 2018 | 87 | 2018 |
| Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma H Köksal, P Dillard, SE Josefsson, SM Maggadottir, S Pollmann, A Fåne, ... Blood advances 3 (8), 1230-1243, 2019 | 47 | 2019 |
| Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression IH Rye, K Huse, SE Josefsson, W Kildal, HE Danielsen, E Schlichting, ... Molecular Oncology 16 (1), 88-103, 2022 | 23 | 2022 |
| TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma. Cancer Immunol. Res. 2019; 7: 355–362. doi: 10.1158/2326-6066 SE Josefsson, K Beiske, YN Blaker, MS Førsund, H Holte, B Østenstad, ... CIR-18-0351.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 14 | |
| Efficient chimeric antigen receptor targeting of a central epitope of CD22 NP Casey, CH Klee, A Fåne, B Caulier, A Graczyk-Jarzynka, M Krawczyk, ... Journal of Biological Chemistry 299 (7), 2023 | 1 | 2023 |
| Diversity of Intratumoral Regulatory T Cells in Non-Hodgkin Lymphoma I Spasevska, A Sharma, CB Steen, S Josefsson, YN Blaker, EH Rustad, ... Blood 138 (Supplement 1), 3519-3519, 2021 | 1 | 2021 |
| Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma I Spasevska, S Josefsson, YN Blaker, CB Steen, A Sharma, K Kushekhar, ... Blood 136, 27-28, 2020 | 1 | 2020 |
| Identification of Tigit on Intra-Tumor T Cells As a New Target for Immune Checkpoint Blockade in Follicular Lymphoma S Gothberg, K Huse, A Kolstad, OC Lingjaerde, B Østenstad, E Smeland, ... Blood 128 (22), 917, 2016 | 1 | 2016 |
| Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma I Spasevska, A Sharma, CB Steen, SE Josefsson, YN Blaker, A Kolstad, ... Blood Advances 7 (23), 7216-7230, 2023 | | 2023 |
| Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma P Dillard, H Köksal, S Josefsson, SM Maggadottir, S Pollmann, A Fåne, ... Cancer Research 79 (13_Supplement), 1422-1422, 2019 | | 2019 |
| Targeting lymphoma with CD37CAR: A pre-clinical study S Walchli, IM Sektioglu, H Köksal, SE Josefsson, A Faane, K Huse, ... Annals of Oncology 28, xi5, 2017 | | 2017 |
| CHARACTERIZATION OF INHIBITORY RECEPTORS ON TUMOR-INFILTRATING T CELLS IN FOLLICULAR LYMPHOMA TO REVEAL NOVEL TARGETS FOR IMMUNOTHERAPY: 150 K Huse, S Göthberg, A Greenplate, A Kolstad, B Østenstad, E Smeland, ... Hematological Oncology 33, 181-182, 2015 | | 2015 |
